Search Results - "ERKER, Thomas"

Refine Results
  1. 1

    A novel prodrug-based strategy to increase effects of bumetanide in epilepsy by Töllner, Kathrin, Brandt, Claudia, Töpfer, Manuel, Brunhofer, Gerda, Erker, Thomas, Gabriel, Mario, Feit, Peter W., Lindfors, Jenna, Kaila, Kai, Löscher, Wolfgang

    Published in Annals of neurology (01-04-2014)
    “…Objective There is considerable interest in using bumetanide, a chloride importer Na‐K‐Cl cotransporter antagonist, for treatment of neurological diseases,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo by Mairinger, Severin, Erker, Thomas, Muller, Markus, Langer, Oliver

    Published in Current drug metabolism (01-10-2011)
    “…Adenosine triphosphate-binding cassette (ABC) transporters, such as P-glycoprotein (Pgp, ABCB1), breast cancer resistance protein (BCRP, ABCG2) and multidrug…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66 by Luo, Lanxin, Wang, Jun, Ding, Dawei, Hasan, Md Nabiul, Yang, Sung-Sen, Lin, Shih-Hua, Schreppel, Philipp, Sun, Baoshan, Yin, Yan, Erker, Thomas, Sun, Dandan

    Published in Frontiers in physiology (31-07-2020)
    “…Introduction: Na + -K + -2Cl − cotransporter isoform 1 (NKCC1) is important in regulating intracellular K + and Cl − homeostasis and cell volume. In this…”
    Get full text
    Journal Article
  6. 6

    GABAA receptor modulation by piperine and a non-TRPV1 activating derivative by Khom, Sophia, Strommer, Barbara, Schöffmann, Angela, Hintersteiner, Juliane, Baburin, Igor, Erker, Thomas, Schwarz, Thomas, Schwarzer, Christoph, Zaugg, Janine, Hamburger, Matthias, Hering, Steffen

    Published in Biochemical pharmacology (15-06-2013)
    “…The action of piperine (the pungent component of pepper) and its derivative SCT-66 ((2E,4E)-5-(1,3-benzodioxol-5-yl))-N,N-diisobutyl-2,4-pentadienamide) on…”
    Get full text
    Journal Article
  7. 7

    Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides by Kucinska, Malgorzata, Giron, Maria-Dolores, Piotrowska, Hanna, Lisiak, Natalia, Granig, Walter H, Lopez-Jaramillo, Francisco-Javier, Salto, Rafael, Murias, Marek, Erker, Thomas

    Published in PloS one (2016)
    “…The cytotoxicity of 27 benzanilides and dithiobenzanilides built on a stilbene scaffold and possessing various functional groups in aromatic rings previously…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Foam cell specific LXRα ligand by Feldmann, Radmila, Geikowski, Anne, Weidner, Christopher, Witzke, Annabell, Kodelja, Vitam, Schwarz, Thomas, Gabriel, Mario, Erker, Thomas, Sauer, Sascha

    Published in PloS one (25-02-2013)
    “…The liver X receptor α (LXRα) is a ligand-dependent nuclear receptor and the major regulator of reverse cholesterol transport in macrophages. This makes it an…”
    Get full text
    Journal Article
  11. 11

    Resveratrol blocks Akt activation in angiotensin II-or EGF-stimulated vascular smooth muscle cells in a redox-independent manner by SCHREINER, Cornelia E, KUMERZ, Mario, GESSLBAUER, Julia, SCHACHNER, Daniel, JOA, Helge, ERKER, Thomas, ATANASOV, Atanas G, HEISS, Elke H, DIRSCH, Verena M

    Published in Cardiovascular research (01-04-2011)
    “…Resveratrol (RV), an antioxidant, inhibits angiotensin II (Ang II)-induced hypertrophy and Ang II- or epidermal growth factor (EGF)-induced Akt phosphorylation…”
    Get full text
    Journal Article
  12. 12

    Synthesis of Novel Curcumin Analogues and Their Evaluation as Selective Cyclooxygenase-1 (COX-1) Inhibitors by Handler, Norbert, Jaeger, Walter, Puschacher, Helmut, Leisser, Klaus, Erker, Thomas

    “…Curcumin, a major yellow pigment and active component of turmeric, has been shown to possess anti-inflammatory and anti-cancer activities. Recent studies have…”
    Get full text
    Journal Article
  13. 13

    Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines by OVESNA, Zdenka, KOZICS, Katarina, BADER, Yvonne, SAIKO, Philipp, HANDLER, Norbert, ERKER, Thomas, SZEKERES, Thomas

    Published in Oncology reports (01-09-2006)
    “…trans-Resveratrol (t-RES) is one of the most relevant and extensively investigated stilbenes with a broad spectrum of biological activities. In contrast to the…”
    Get full text
    Journal Article
  14. 14

    Using structural and mechanistic information to design novel inhibitors/substrates of P-glycoprotein by Klepsch, Freya, Stockner, Thomas, Erker, Thomas, Müller, Markus, Chiba, Peter, Ecker, Gerhard F

    Published in Current topics in medicinal chemistry (01-12-2010)
    “…Design of inhibitors of P-glycoprotein still represents a challenging task for medicinal chemists. The polyspecificity of the transporter combined with the…”
    Get more information
    Journal Article
  15. 15

    Novel Resveratrol Derivatives Induce Apoptosis and Cause Cell Cycle Arrest in Prostate Cancer Cell Lines by Horvath, Z, Marihart-Fazekas, S, Saiko, P, Grusch, M, Oezsuey, M, Harik, M, Handler, N, Erker, T, Jaeger, W, Fritzer-Szekeres, M, Djavan, B, Szekeres, T

    Published in Anticancer research (01-09-2007)
    “…Background: Resveratrol (RV), a naturally occurring phytoalexin, exerts manifold biological effects against a variety of human tumor cell lines. In this study,…”
    Get full text
    Journal Article
  16. 16

    Impaired chloride homeostasis in epilepsy: Molecular basis, impact on treatment, and current treatment approaches by Auer, Theresa, Schreppel, Philipp, Erker, Thomas, Schwarzer, Christoph

    Published in Pharmacology & therapeutics (Oxford) (01-01-2020)
    “…Epilepsies represent one of the most common neurological diseases worldwide. They are characterized by recurrent spontaneous seizures with severe impact on a…”
    Get full text
    Journal Article
  17. 17

    Functional characterization of novel bumetanide derivatives for epilepsy treatment by Auer, Theresa, Schreppel, Philipp, Erker, Thomas, Schwarzer, Christoph

    Published in Neuropharmacology (01-01-2020)
    “…Temporal lobe epilepsy (TLE) is the most common type of focal epilepsies, affecting approximately 35 million people worldwide. Despite the introduction of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effects of Novel Synthesized Pyridothiazines on Various Guinea Pig Heart Muscle Preparations by Schade, Bettina, Erker, Thomas, Weber, Manuela, Studenik, Christian

    Published in Biological & Pharmaceutical Bulletin (01-09-2004)
    “…Calcium channel blockers have become important tools in the treatment of cardiovascular disorders and other diseases. Hybridization of well established calcium…”
    Get full text
    Journal Article
  20. 20

    Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain by Römermann, Kerstin, Fedrowitz, Maren, Hampel, Philip, Kaczmarek, Edith, Töllner, Kathrin, Erker, Thomas, Sweet, Douglas H., Löscher, Wolfgang

    Published in Neuropharmacology (01-05-2017)
    “…There is accumulating evidence that bumetanide, which has been used over decades as a potent loop diuretic, also exerts effects on brain disorders, including…”
    Get full text
    Journal Article